(“ArkBio”) announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a ...

Moderna’s top executives have sought to reassure investors they will be able to carry out the comeback plans announced in ...

Needham & Company LLC reiterated their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a report ...

It’s unlikely Robert F. Kennedy Jr. could stop all vaccines from being distributed. However, if confirmed, he could exert ...

Stewart-Haas' sad demise belies its legacy of unlikely success (October 31, 2024, 7:00 PM ET) ...